MAJOR CANCER RESEARCH BREAKTHROUGH: IVERMECTIN STUDY PUBLISHED IN ANTICANCER RESEARCH JOURNAL (opens in new tab)

Recently, The Wellness Company announced a first of its kind human observational study of the off-label use of Ivermectin and Mebendazole in the treatment of cancer was published by the Anticancer Research Journal. Dr. Peter McCullough, Chief Scientific Officer for The Wellness Company, and one of the authors of the […] The post appeared first on <a href="